New Human H5N1 Bird Flu Vaccine From Baxter Shows Promise In Trial
Jun 12th 2008Drug InformationBird Flu
Results of a phase I and phase II trial on a new human vaccine against the deadly H5N1 bird flu virus that is made from cell culture instead of embryonated eggs (making it faster and cheaper to produce) show that it is safe and effective against a number of divergent strains. The experimental vaccine is made by Baxter International.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
